Status:

COMPLETED

Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics

Lead Sponsor:

Hospital Juarez de Mexico

Conditions:

Type 2 Diabetes

Type 2 Diabetes With Renal Manifestations

Eligibility:

All Genders

18-65 years

Brief Summary

According to the different epidemiological studies in Mexico the prevalence of diabetic nephropathy is 9.1%-40% in diabetic patients, however the complication is subdiagnosed when we see the numbers o...

Detailed Description

Type 2 diabetes (T2D) is defined as a group of metabolic diseases characterized by chronic hyperglycemia, resulting from defects in insulin secretion, insulin action or both. According to the National...

Eligibility Criteria

Inclusion

  • Patients with ≥ 20 years of T2D evolution with normoalbuminuria
  • Patients without a personal or family history of kidney disease in 1st degree relatives Age ≥ 18 years
  • T2D diagnosed at least 5 years before initiating renal replacement therapy Background or diabetic retinopathy by self-report to ensure that albuminuria was the consequence of diabetic nephropathy rather than a non-diabetic glomerulopathy albuminuria ≥ 300 mg/24 h in at least two out of three sterile urine samples no hematuria or signs (including cellular casts), history or predisposition to other kidney or urinary tract disease.

Exclusion

  • Diabetic patients without diabetic nephropathy
  • Patients with type 1 diabetes, gesta- tional diabetes, uncontrollable hypertension, active cancer, heart failure, liver or kidney disease, cotreatment with corticosteroids or estrogens, conditions that can cause hyperglycemia, addiction to alcohol or illegal drugs, and dementia or severe psychiatric disor- ders were not included in this study

Key Trial Info

Start Date :

September 3 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 28 2023

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05378282

Start Date

September 3 2021

End Date

February 28 2023

Last Update

February 28 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Juárez de México

Mexico City, Mexico, 07760